Skip to search formSkip to main contentSkip to account menu

Montanide ISA-51/peptide 946-tetanus peptide conjugate melanoma vaccine

Known as: ISA-51/p946-Tet p, ISA-51/p946/Tet p, Montanide ISA-51/peptide 946 melanoma vaccine/tetanus peptide melanoma vaccine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
A central goal in vaccinology is the induction of high and sustained Ab responses. Protein-in-adjuvant formulations are commonly… 
2006
2006
BACKGROUND A prophylactic vaccine for hepatitis C virus (HCV) requires generation of strong humoral as well as CD4(+) and CD8… 
Highly Cited
2004
Highly Cited
2004
Previous studies in small groups of patients suggested that immunization of melanoma patients with peptide epitopes recognized by… 
2004
2004
Introduction: The UBITh ® -VP1 synthetic peptide-based vaccine for FMDV O, formulated as a water-in-oil emulsion, was evaluated…